Short-Term Testosterone Replacement Improved Sexual and Physical Function After Radical Prostatectomy Without Biochemical Recurrence in Carefully Selected Prostate Cancer Survivors
Posted innews Oncology Urology

Short-Term Testosterone Replacement Improved Sexual and Physical Function After Radical Prostatectomy Without Biochemical Recurrence in Carefully Selected Prostate Cancer Survivors

A phase 2 randomized trial found that 12 weeks of testosterone cypionate improved sexual activity, desire, mood, body composition, and exercise performance in hypogonadal men after radical prostatectomy, with no biochemical recurrence observed during the study period.
Association of Testosterone-Induced Neutrophil and Monocyte Elevation with Thromboembolic Risk: Insights from the TRAVERSE Trial
Posted inCardiology Diabetes & Endocrinology news Specialties

Association of Testosterone-Induced Neutrophil and Monocyte Elevation with Thromboembolic Risk: Insights from the TRAVERSE Trial

The TRAVERSE trial reveals that testosterone replacement therapy elevates neutrophil and monocyte counts in hypogonadal men, correlating with increased venous thromboembolism and cardiovascular event risk, underscoring the need to monitor these leukocytes during therapy.